未登录

W

Wojciech Pasławski

Department of Clinical Neuroscience

H指数:15

被引数:1,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder

脑脊液甘丙肽和去甲肾上腺素在重度抑郁症中通过裸盖菇素疗法下调

Neuropsychopharmacology

IF7.1

2026-07-070

OA

Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons

Bri2 BRICHOS，一种分子伴侣样结构域，能够穿过脑血管内皮细胞并将蛋白质递送至神经元

Journal of Controlled Release

IF11.5

2025-11-100

OAAI

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

高水平脑脊液多巴脱羧酶可预测帕金森病患者的认知下降

MOVEMENT DISORDERS CLINICAL PRACTICE

IF2.7

2025-09-010

OAAI

Parkinson disease-associated toxic exposures selectively up-regulate vesicular glutamate transporter vGlut2 in a model of human cortical neurons

帕金森病相关的毒性暴露在人类皮质神经元模型中选择性上调囊泡谷氨酸转运体vGlut2

MOLECULAR BIOLOGY OF THE CELL

IF2.7

2025-02-010

PRE

Coelimycin inside out - negative feedback regulation by its intracellular precursors

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IF4.3

2024-12-100

OAAI

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease

TRANSLATIONAL NEURODEGENERATION

IF15.2

2024-06-110

OAAI

Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts

MOVEMENT DISORDERS

IF7.6

2024-05-262

OA

Maternal deprivation causes CaMKII downregulation and modulates glutamate, norepinephrine and serotonin in limbic brain areas in a rat model of single prolonged stress

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2024-03-014

OAAI

Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients - Validation in the BioFIND cohort

PARKINSONISM & RELATED DISORDERS

IF3.4

2023-11-012

OAAI

Isolation of L1CAM-Extracellular Vesicles Reveals Signs of Insulin Resistance in Parkinson's Disease

MOVEMENT DISORDERS

IF7.6

2023-09-053

OAAI

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease

TRANSLATIONAL NEURODEGENERATION

IF15.2

2023-09-0413

OAAI

Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation

STEM CELL REPORTS

IF5.1

2023-01-0112

OAAI

PRC2-mediated repression is essential to maintain identity and function of differentiated dopaminergic and serotonergic neurons

SCIENCE ADVANCES

IF12.5

2022-08-269

OAAI

α-Synuclein induced cholesterol lowering increases tonic and reduces depolarization-evoked synaptic vesicle recycling and glutamate release

NPJ PARKINSONS DISEASE

IF8.2

2022-06-075

OAAI

Toward Novel [18F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2022-04-298

OAAI

Cerebrospinal Fluid Proteins Altered in Corticobasal Degeneration

MOVEMENT DISORDERS

IF7.6

2021-03-045

OA

Ecto-GPR37: a potential biomarker for Parkinson's disease

TRANSLATIONAL NEURODEGENERATION

IF15.2

2021-02-2622

OAAI

P11 deficiency increases stress reactivity along with HPA axis and autonomic hyperresponsiveness

MOLECULAR PSYCHIATRY

IF10.1

2020-10-0117

OAAI

Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's Disease

MOVEMENT DISORDERS

IF7.6

2020-08-1514

OAAI

α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2019-07-0337

OAAI